期刊文献+

色素上皮衍生因子治疗年龄相关性黄斑变性的研究进展 被引量:1

Progress on study of treatment of age-related macular degeneration by pigment epithelial-derived factor
原文传递
导出
摘要 年龄相关性黄斑变性(AMD)是世界范围内老年人致盲的主要疾病之一,探索治疗AMD的有效方法具有防盲治盲的重要意义。色素上皮衍生因子(PEDF)是最强效的内源性新生血管抑制剂,大量基础研究及Ⅰ期临床试验的结果表明,PEDF可有效治疗以脉络膜新生血管形成为主要特征的湿性AMD,因此,PEDF已成为目前最具潜能的治疗AMD的首选药物之一。 Age-related macular degeneration (AMD) is a common cause of blindness in elderly population. Exploration of effective treatment of AMD has important significance. Pigment epithelial-derived factor (PEDF) is the most powerful endogenous inhibitor of angiogenesis. Increasing evidences, including results of phase Ⅰ clinical trial, indicated that PED17 could significantly inhibit the development of choroidal neovascularization, which is the characteristic of wet AMD. Therefore, PEDF is one of the most potential therapeutic agents for AMD treatment
出处 《中华眼科杂志》 CAS CSCD 北大核心 2010年第2期181-185,共5页 Chinese Journal of Ophthalmology
关键词 黄斑变性 脉络膜新生血管化 眼蛋白质类 神经生长因子类 舍平类 Macular degeneration Choroidal neovascularization Eye proteins Nerve growth factors Serpins
  • 相关文献

参考文献41

  • 1Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res, 2009,28 : 1-18.
  • 2Noel A, Jost M, Lambert V, et al. Anti-angiogenic therapy of exudative age-related maeular degeneration: current progress and emerging concepts. Trends Mol Med, 2007,13:345-352.
  • 3Eichler W, Yafai Y, Wiedemann P, et al. Antineovaseular agents in the treatment of eye diseases. Curt Pharm Des, 2006,12:2645- 2660.
  • 4Oshima Y, Oshima S, Nambu H, et al. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J Cell Physiol, 2004,201:393-400.
  • 5Afzal A, Shaw LC, Ljubimov AV, et al. Retinal and choroidal microangiopathies : therapeutic opportunities. Microvasc Res, 2007,74 : 131-144.
  • 6Nishijima K, Ng YS, Zhang L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol, 2007,171:53-67.
  • 7Verheul HM, Pinedo HM. Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition. Nat Rev Cancer, 2007,7:475-485.
  • 8Barnstable C J, Tombran-Tink J. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential. Prog Retin Eye Res, 2004,23:561-577.
  • 9Becerra SP. Focus on molecules: pigment epithelium-derived factor (PEDF). Exp Eye Res, 2006,82:739-740.
  • 10Tong JP, Yao YF. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin Biochem, 2006,39:267-276.

同被引文献20

  • 1Kaarniranta K, Hyttinen J, Ryhanen T, et al. Mechanisms of protein aggregation in the retinal pigment epithelial ceils. Front Biosci ( Elite Ed) ,2010,2 : 1374-1384.
  • 2de Jong PT. Age-related macular degeneration. N Engl J Med, 2006,355 : 1474-1485.
  • 3Mennel S, Peter S, Meyer CH, et al. Effect of photodynamic therapy on the function of the outer blood-retinal barrier in an in vitro model. Graefes Arch Clin Exp Ophthalmol,2006,244 : 1015-1021.
  • 4Simo R, Villarroel M, Corraliza L, et al. The retinal pigment epithelium:something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechno1,2010,2010 : 190724.
  • 5Singh AB, Harris RC. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J Biol Chem,2004,279:3543-3552.
  • 6Honda M, Nakagawa S, Hayashi K, et al. Adrenomedullin improves the blood-brain barrier function through the expression of claudin- 5. Cell Mol Neurobiol,2006,26 : 109-118.
  • 7Peng S, Rahner C, Rizzolo LJ. Apical and basal regulation of the permeability of the retinal pigment epithelium. Invest Ophthalmol Vis Sci ,2003,44:808-817.
  • 8Slomiany MG,Rosenzweig SA. IGF-l-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line IM07. Invest Ophthalmol Vis Sci ,2004,45:2838-2847.
  • 9Kirschner N, Bohner C, Rachow S, et al. Tight junctions : is there a role in dermatology? Arch Dermatol Res,2010,302:483-493.
  • 10Gonzalez JE, DiGeronimo R J, Arthur DE, et al. Remodeling of the tight junction during recovery from exposure to hydrogen peroxide in kidney epithelial ceils. Free Radic Biol Med ,2009 ,47 :1561-1569.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部